Investment Memo: Figure AI
Company: Figure AI (founded 2022, Brett Adcock) Sector: Humanoid robotics — warehouse & manufacturing labor Stage considered: Hypothetical Series A
---
Thesis
The labor market for repetitive physical work is enormous and structurally undersupplied. US warehousing and manufacturing alone employ ~13M people; turnover in warehouse roles routinely exceeds 40% annually, and manufacturers report hundreds of thousands of unfilled positions. If a general-purpose humanoid can perform even a narrow band of these tasks at a fully-loaded cost below ~$15–25/hour equivalent, the addressable spend is measured in hundreds of billions of dollars — not a robotics market, a labor market.
The fund-returner case: humanoids are the rare category where the winner could be a $100B+ company, because the form factor amortizes across every human-built environment without facility retrofits. Recent step-changes in foundation models for vision-language-action (VLA) control have compressed the timeline from "decades" to "plausibly this decade." Figure is one of perhaps four credible Western contenders, founded by a repeat founder (Archer Aviation, Vettery) who has demonstrated he can recruit elite hardware talent and raise capital at scale. In a category where capital access is itself a moat, Figure's ability to raise mega-rounds is a strategic asset, not just dilution.
Product & Wedge
Figure builds general-purpose bipedal humanoids (Figure 01, Figure 02, and the newer Figure 03) with dexterous hands, onboard compute, and a proprietary VLA model ("Helix") after ending its OpenAI collaboration in early 2025 to bring AI in-house. The wedge is deliberate: structured, repetitive, single-station tasks in logistics and manufacturing — tote handling, machine tending, parts sequencing — where the environment is semi-controlled and ROI math is legible. The company has publicly discussed its BotQ manufacturing facility with stated ambitions to produce thousands of units annually, signaling a bet on vertical integration of manufacturing itself.
The wedge logic is sound: win one narrow, high-turnover task class, deploy at customer sites for data flywheel, and expand task coverage via software rather than new hardware SKUs.
Market & Competition
TAM: Global logistics + manufacturing labor spend exceeds $1T. Even a 1% penetration at robot-as-a-service pricing implies a $10B+ revenue opportunity.
Competitors (real and serious):
- Tesla Optimus — the existential threat: manufacturing scale, in-house AI, captive first customer (Tesla factories), and Musk's cost-down discipline.
- Agility Robotics (Digit) — furthest along in actual warehouse deployments (GXO, Amazon pilots); purpose-built for logistics rather than general humanoid ambitions.
- Boston Dynamics (electric Atlas) — Hyundai-backed, best-in-class hardware, now pivoting to commercial manufacturing use.
- 1X Technologies, Apptronik (Apollo) — well-funded; Apptronik has a Mercedes-Benz pilot and Google DeepMind partnership.
- Chinese entrants (Unitree, UBTech, Fourier) — aggressive on cost; Unitree sells humanoids at price points Western firms can't yet touch.
Differentiation among Western players is currently narrative-heavy and data-light. No one has demonstrated durable, unattended commercial operation at scale.
Traction & Business Signal (publicly known)
- BMW Spartanburg partnership (announced Jan 2024): Figure 02 units performing sheet-metal placement tasks; scope and unit count beyond pilot scale — unknown. Media reporting has questioned the depth of deployment.
- Second commercial customer referenced by the company (widely reported to be a major logistics player, unconfirmed by Figure) — details unknown.
- Financing: ~$675M Series B (Feb 2024) at ~$2.6B valuation from OpenAI Startup Fund, Microsoft, NVIDIA, Bezos Expeditions, Intel Capital; a 2025 round reported at ~$39B valuation.
- Revenue, unit economics, units deployed, uptime, tasks-per-hour vs. human baseline: all unknown.
- Ended OpenAI partnership Feb 2025, claiming in-house Helix breakthrough — unverified externally.
Net: strong capital and demo signal; essentially zero public evidence of commercial-scale performance.
Risks (the three that kill the deal)
- The reliability gap is unsolved and may be far away. Demos ≠ deployment. A robot that succeeds 95% of the time is commercially useless in a line-rate manufacturing environment; humans are 99.9%+ with graceful failure recovery. If closing the last 4.9% takes 7–10 years, Figure burns through even billions before revenue matters. This is the deal-killer.
- Tesla and Chinese cost curves. If humanoid hardware commoditizes (Unitree already signals this) and the differentiator becomes the AI model plus manufacturing scale, Figure competes against Tesla's factories and Google-scale AI labs with neither advantage. Capital access alone doesn't win a hardware cost war.
- Governance/narrative risk. Founder-driven hype cycles (a 15x valuation jump in ~18 months with unknown revenue), a disputed partnership scope, and the abrupt OpenAI split raise the question of whether public claims track internal reality. In hardware, narrative-reality gaps compound fatally.
Verdict
Invest at Series A — with sized, eyes-open conviction (1–1.5% of fund, not a concentrated bet). At Series A pricing, the asymmetry works: the category is real, the founder recruits and raises exceptionally, and the downside is a known quantity while the upside is a generational company. At the reported later-stage valuations, pass — the risk is Series A-shaped and the price is not.
The one question I need answered first: At the BMW deployment, what is the current mean-time-between-human-intervention, and how has it trended over the last six months? That single curve tells you whether this is a five-year business or a fifteen-year science project.